Gilead Sciences, Inc.
GILD
$118.37
-$0.65-0.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 498.77% | 1,129.90% | -91.53% | -97.86% | -80.78% |
| Total Depreciation and Amortization | 0.51% | 1.09% | 2.75% | 9.04% | 16.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.07% | -58.76% | 333.68% | 451.89% | 315.82% |
| Change in Net Operating Assets | 53.09% | 34.50% | 61.79% | -16.01% | -1,841.71% |
| Cash from Operations | 32.14% | 22.23% | 35.25% | 19.25% | -21.49% |
| Capital Expenditure | 12.76% | 10.15% | 10.60% | -7.26% | 2.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 79.38% | 76.96% | -320.14% | -362.33% | -211.85% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -222.54% | -104.12% | 462.50% | 721.40% | 571.51% |
| Cash from Investing | 0.12% | 54.55% | -52.27% | -106.53% | -44.76% |
| Total Debt Issued | 74.95% | 74.95% | 74.95% | -99.95% | -- |
| Total Debt Repaid | 53.91% | -65.87% | 12.44% | 12.76% | -310.10% |
| Issuance of Common Stock | 111.54% | 87.90% | 81.90% | -28.01% | -22.39% |
| Repurchase of Common Stock | -100.74% | -48.00% | -15.00% | 42.14% | 37.58% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.64% | -2.82% | -2.86% | -2.83% | -2.69% |
| Other Financing Activities | -40.30% | -30.27% | -1.08% | 0.37% | -11.91% |
| Cash from Financing | 40.68% | -8.23% | 33.01% | -21.72% | -12.19% |
| Foreign Exchange rate Adjustments | 3,950.00% | -111.54% | -170.18% | -45.26% | -93.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 180.90% | 1,571.56% | 480.39% | -166.50% | -403.83% |